Patent · US Active

Hepatitis C virus inhibitors

US8383094B2 · kind B2 · utility

3Cited by

1References

18Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

Makonen Belema · North Haven, US
Van N. Nguyen · West Haven, US
Michael H. Serrano-Wu · Cambridge, US
Denis R. St. Laurent · Newington, US
Yuping Qiu · Princeton Junction, US
Min Ding · Dobbs Ferry, US
Nicholas A. Meanwell · East Hampton, US
Lawrence B. Snyder · Killingworth, US

Key dates

Filing date	Sep 29, 2009
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Dec 11, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.